Background: Thyroid cancers are threefold more frequent in women than in men. A
| INTRODUC TI ON
Incidence of thyroid cancer has increased worldwide over the recent decades.
1,2 Some established risk factors for thyroid cancer are known, such as ionizing radiation, benign thyroid disease, genetic predisposal and high body mass index (BMI). 1, 3, 4 Based on epidemiological data, it has long been proposed that hormonal factors may determine or modulate the risk of thyroid cancer. Indeed, thyroid cancers are threefold more frequent in women than in men after puberty and incidence decreases after menopause. 5, 6 A role of female hormones in the aetiology of thyroid cancer has been suggested with a direct action of oestrogens, via its receptors (ER), on proliferative and neoplastic disorders. 6 However, the relationship between thyroid cancer risk and reproductive or hormonal factors is still debated, with contradictory and often inconclusive findings on the association between thyroid cancer and age at puberty, menopause, parity, breast-feeding or menopausal hormone therapy. 5, [7] [8] [9] Hysterectomy is one of the most common surgical procedures in gynaecology worldwide and is mainly performed in case of a benign disease such as fibroma and endometriosis, conditions which are associated with lifetime sex steroid hormone exposure. [10] [11] [12] Several studies have attempted to determine hormonal and reproductive factors involved in the development of thyroid cancer in women, with conflicting results. 5, 9, 13 A potential association between hysterectomy and thyroid cancer risk has already been described, but in studies with methodological heterogeneities and potential bias. 7, [14] [15] [16] [17] Moreover, links between thyroid cancer risk and hysterectomy, oophorectomy or benign gynaecological disease histories have not been investigated simultaneously, despite common aetiological factors and frequent morbid associations. Thus, we aimed to prospectively explore the link between differentiated thyroid cancer (micro-or macro-carcinomas) and a history of hysterectomy, with or without oophorectomy, in a large cohort, according to age and time since gynaecological surgery. In addition, we investigated the relation between a history of benign gynaecological disease (uterine fibroids, endometriosis, ovarian cyst and uterine polyp) and the risk of incident thyroid cancer.
| MATERIAL S AND ME THODS

| The E3N cohort
TheE3N cohort study (Etude Epidemiologique de Femmes de la Mutuelle Générale de l'Education Nationale) is a prospective cohort of 98 995 French women born between 1925 and 1950 and insured by a national health system primarily covering teachers.
18
Participants have received 11 follow-up questionnaires (mailed every 2-3 years) and responded to each at a rate of ~80%. 18 The women were enrolled in 1990 after they returned a baseline self-administered questionnaire on their lifestyle and medical history. All women signed an informed consent, in compliance with the rules of the French National Commission for Data Protection and Individual
Freedom from which approval was obtained.
| Thyroid disease assessment
Each questionnaire inquired about cancer occurrence, and requested information and permission to contact participants' physicians.
Cases were confirmed by pathology reports. analyzed as time-dependent variables. When the variables were not available at a given questionnaire, the preceding value was considered until the next known value. The proportional hazard hypothesis was verified for all time-independent variables of interest using log-log survivor plots. Covariates included in the models used are listed in Tables   2 and 3 . Information on time-dependent variables was updated at each questionnaire. Missing values for all adjustment variables were replaced by the modal value, as they were missing for less than 5% of women.
| Population for analysis
| Statistical analyses
We performed stratified analyses to explore associations according to tumour size (micro-(<10 mm) or macro-(≥10 mm) carcinoma) using competing-risk models. Cases with missing values on tumour size were excluded from these analyses, and analyses were performed in each strata by censoring the cases belonged to the other strata at date of diagnosis.
We used homogeneity tests to compare risk estimates across strata using the Wald chi-square statistic.
Smoking status and a history of dysthyroidism were evaluated as potential effect modifiers by adding an interaction term in the final model and testing statistical significance. All tests were two-sided, and statistical significance (P-value) was set at the 0.05
level. All analyses were performed using Statistical Analysis Systems (SAS) software, version 9.3 (SAS Institute, Inc, Cary, North Carolina).
| RE SULTS
Among 89 340 women considered in the present analysis, 412
cases of first primary differentiated thyroid cancer (381 papillary and 31 follicular) were diagnosed during 1 603 264 person-years of observation (median follow-up duration of 9.9 years for cases and 21.4 years for non-cases). Of the 412 cases of thyroid cancer, the information on the micro-or macro-carcinoma status was missing for 9. A total of 166 (41%) were considered as micro-carcinoma (size <10 mm) and 237 were macro-carcinoma (size ≥10 mm).
As shown in Table 1 , the frequency of goitre/thyroid nodules was similar between women with an history of hysterectomy and those who did not have hysterectomy. The prevalence of excessive weight or obesity was higher among the women with an history of hysterectomy as compared to those without hysterectomy.
| Hysterectomy/Oophorectomy and risk of thyroid cancer
Women with a history of hysterectomy had an increased risk of differentiated thyroid cancer (HR=2.05, 95%CI 1.65-2.55; model 2), as compared to women without hysterectomy ( Figure 1 , Table 2 ). When considering types of hysterectomy/oophorectomy, the highest risk was observed for women with hysterectomy and uni-or bilateral oophorectomy (HR=2.21, 95%CI 1.67-2.91). There was no association between oophorectomy alone and thyroid cancer risk. Risks were similar whatever the age at the hysterectomy or the time since hysterectomy. Associations were similar although slightly stronger after adjustment for reproductive factors (model 3) ( 
| Fibroids
Overall, a history of benign gynaecological disease confirmed by surgery or laparoscopy was associated with increased thyroid cancer risk (HR 1.67, 95%CI 1.32-2.11; model 2; Table 3 ). The increase was driven by the association with uterine fibroids history (HR 1.91; 95% CI 1.50-2.44, model 2; Table 3 ). This association was observed whatever the mode of diagnosis of fibroids and irrespective of a history of hysterectomy ( Neither self-reported nor confirmed history of endometriosis, uterine polyps or ovarian cysts were associated with thyroid cancer risk ( Table 3) . Results were similar for papillary and follicular thyroid cancers (data not shown).
Finally, we performed sensitivity analyses by excluding women who had an early diagnosis of thyroid cancer (first 2 years of follow-up) and the results were unchanged: women with a history of hysterectomy had an increased risk of differentiated thyroid cancer (HR=2.01, 95%CI
1.60-2.52; model 2), as compared to women without hysterectomy.
Similarly, those who had a history of uterine fibroma were at higher risk of thyroid cancer as well (HR 1.84; 95% CI 1.47-2.30, model 2). 
| D ISCUSS I ON
In this large prospective study with more than 400 incident thyroid cancer cases occurring in women aged 40-65 at baseline, we found a positive relationship between the risk of differentiated thyroid cancer and a history of hysterectomy, but not with a history of oophorectomy. Results were similar whatever the age at hysterectomy or time since hysterectomy. We observed also an association between a history of fibroids and the risk of thyroid cancer, which appears to be independent of a history of hysterectomy.
| Hysterectomy/oophorectomy status and risk of thyroid cancer
A recent meta-analysis reported an association between a history of hysterectomy and the risk of thyroid cancer with a summary relative risk (SRR) of 1.43. 5 However, the results were contrasting as only five out of 24 studies found that hysterectomy was associated with an increased risk of thyroid cancer. Other studies focusing specifically on the link between differentiated thyroid cancer risk and a history of hysterectomy were also conflicting. 7, 11, 14, 15, 17, 19, 20 Methodological flaws may partly explain these discrepancies, due to case-control design and retrospective self-reported surgery history.
Besides, studies concluding that there was a positive relationship between a history of hysterectomy and thyroid cancer risk did not perform adjustment on history of benign thyroid disease or family history of thyroid cancer, and thus could not discard the possibility of confounding.
14,15,17,19
In contrast to previous studies, 14,15,17 we did not observe any change in the association between hysterectomy and the risk of thyroid cancer in relation to the time elapsed since hysterectomy or according to the age at hysterectomy. This finding is an argument TA B L E 2 Hazard ratios (HRs) and 95% confidence intervals (95% CI) for differentiated thyroid cancer according to medical history of hysterectomy. E3N cohort, 1990-2011 (n = 89 340) M3: M2 further adjusted for age at menarche (<13 years/≥13 years), use of oral contraceptives (ever/never, time-dependent), infertility treatment (ever/never, last assessed in 1992), parity and age at first full-term pregnancy (nulliparous/one child at age <30/one child at age ≥30/two children or more, the first at age <30/two children or more, the first at age ≥30), age at menopause and use of MHT (premenopausal/postmenopausal with no recent use of MHT/postmenopausal with recent use of MHT/postmenopausal with use of MHT but unknown recency, time-dependent).
against a potential detection bias associated with gynaecological surgery. However, we cannot exclude such a detection bias.
It could be speculated that thyroid cancer may be more likely to be found among women with hysterectomy or fibroids, because of medical attention received, as compared to those without the conditions. However, the slightly stronger relation observed between hysterectomy or fibroids and macro-cancers compared with micro-cancers is not in favour of a potential screening bias, which involved the detection of a majority of micro-carcinoma.
Surgically induced menopause, often defined in studies as hysterectomy and/or bilateral oophorectomy has previously been associated with an increased risk of thyroid cancer. BMI, body mass index; HT, hysterectomy; MHT, menopausal hormone therapy M1: Model adjusted for age (timescale), and stratified by 5-year category birth cohort (to consider a potential age-cohort effect) M2: M1 further adjusted for smoking status (ever/never, time-dependent), history of dysthyroidism (hyperthyroidism or hypothyroidism) (ever/never, time-dependent), history of other benign thyroid disease (nodule or goitre) (ever/never, time-dependent) and BMI (<18.5/[18.5-22.5[/ [22.5-25[/ [25-30 [/≥30, time-dependent) M3: M2 further adjusted for age at menarche (<13 years/≥13 years), use of oral contraceptives (ever/never, time-dependent), infertility treatment (ever/never, last assessed in 1992), parity and age at first full-term pregnancy (nulliparous/one child at age <30/one child at age ≥30/two children or more, the first at age <30/two children or more, the first at age ≥30), age at menopause and use of MHT (premenopausal/postmenopausal with no recent use of MHT/postmenopausal with recent use of MHT/postmenopausal with use of MHT but unknown recency, time-dependent).
| Benign gynaecological diseases history and risk of thyroid cancer
Our study revealed a positive association between a history of fibroids and the risk of differentiated thyroid cancer, which is consistent with the relationship between hysterectomy and thyroid cancer as uterine fibroids are the most common cause of hysterectomy.
12
The twofold increased risk of thyroid cancer linked to surgically treated fibroids was similar to results reported in two American studies.
11,15
Studies on the relationship between endometriosis history and thyroid cancer risk are more conflicting, with HR/SIR varying between 0.85 and 3.09. Only two studies found an increased risk of thyroid cancer in women with an endometriosis evolving from more than 5 years 23 and in parous women. 24 It may reflect discrepancies in the definition of endometriosis cases, differences in the populations and the design of the studies: some used retrospective cohort of infertile women, 25 other used data extracted from inpatient and cancer registers 23, 24, 26 or self-reported endometriosis history.
12
As previous studies, 11 we found no relationship between an ovarian cyst history and thyroid cancer risk, which is in line with the lack of link between oophorectomy and thyroid cancer in our study.
Our results seem not to be related to detection bias. Uterine fibroids are the most common pelvic tumours, occurring in nearly 70%
of all reproductive-aged women. 12 Hyper-or hypothyroidism both enhance the likelihood of their diagnosis or treatment 27 by causing abnormal uterine bleeding and have been linked with an increased risk of differentiated thyroid cancer. 28, 29 However, the fact that we found a similar thyroid cancer risk whatever the time elapsed since surgery argues against this. Moreover, the slightly stronger relation observed between hysterectomy or fibroids and macro-cancers compared with micro-cancers is not in favour of a potential screening bias. 
| Potential mechanisms linking uterine fibroids and differentiated cancer thyroid
| Strengths and limits
Strengths of our study include its prospective design, large sample size, histological confirmation of all thyroid cancer cases and availability of data for most differentiated risk factors including a history of benign thyroid conditions. Exposure data were collected before diagnosis of thyroid cancer, avoiding potential recall biases. To our knowledge, it is the first study that investigated an association between hysterectomy, uterine fibroids and micro-and macro-thyroid cancer risk.
This cohort is not representative of the French population and our results cannot be extrapolated to the entire French population.
As in all observational studies, residual confounding may subsist.
Misclassification of exposure status is a potential limitation because of the self-reported assessment of surgery, benign gynaecological and thyroid diseases. Moreover, when we restricted the analysis to the treated cases, the associations remain consistent. Women included in our study, although younger than in the WHI and PLCO studies, were mostly postmenopausal, and our results may not be generalizable to young premenopausal women.
| CON CLUS ION
Our findings showed that hysterectomy or a history of fibroids were associated with a twofold increased risk of differentiated thyroid cancer (micro-and macro-carcinomas) in mostly postmenopausal women. This relation might be explained by common signalling pathways regulated by oestrogen, progesterone or TSH/thyroid hormones. Further studies are needed to delineate the underlying molecular mechanisms or pathways.
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